Prospective Assessment of TBDx Feasibility

Clinical trial NCT02912832 · COMPLETED

Trial details

NCT number: NCT02912832
Sponsor: Foundation for Innovative New Diagnostics, Switzerland
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2014-10-01
Primary completion: 2015-03-01
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.